During a live event, Taha Al-Juhaishi, MD, discussed long-term outcomes of treating blastic plasmacytoid dendritic cell neoplasm and how to navigate toxicities and transplant.

Our whole mission is to help our customers spend less,” Glyman told Fortune. That goal has made the company one of the hottest startups on the market.

Discover how Comparable Company Analysis (CCA) helps investors assess the value of businesses using industry metrics, ...